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Syncope is defined as a transient loss of consciousness and postural tone, characterized
by rapid onset, short duration, and spontaneous recovery, and the process of syncope
progression is here described with two types of sympathetic change. Simultaneous
recordings of microneurographically-recorded muscle sympathetic nerve activity (MSNA)
and continuous and noninvasive blood pressure measurement has disclosed what
is going on during the course of syncope progression. For vasovagal or neurally
mediated syncope, three stages are identified in the course of syncope onset,
oscillation, imbalance, and catastrophe phases. Vasovagal syncope is characterized
by sympathoexcitation, followed by vagal overcoming via the Bezold-Jarisch reflex.
Orthostatic syncope is caused by response failure or a lack of sympathetic nerve activity
to the orthostatic challenge, followed by fluid shift and subsequent low cerebral perfusion.
Four causes are considered for the compensatory failure that triggers orthostatic
syncope: hypovolemia, increased pooling in the lower body, failure to activate sympathetic
activity, and failure of vasoconstriction against sympathetic vasoconstrictive stimulation.
Many pathophysiological conditions have been described from the perspectives of (1)
exaggerated sympathoexcitation and (2) failure to activate the sympathetic nerve. We
conclude that the sympathetic nervous system can control cardiovascular function,
and its failure results in syncope; however, responses of the system obtained by
microneurographically-recorded MSNA would determine the pathophysiology of the onset
and progression of syncope, explaining the treatment effect that could be achieved by the
analysis of this mechanism.
Keywords: syncope, vasovagal syncope, orthostatic hypotension, muscle sympathetic nerve activity, neurally
mediated syncope
INTRODUCTION
Syncope is defined as a transient loss of consciousness and pos-
tural tone, characterized by rapid onset, short duration, and
spontaneous recovery, due to global cerebral hypoperfusion that
most often results from hypotension. The accurate definition
does not include the unconsciousness not caused by cerebral
hypoperfusion, for example, epileptic seizures, concussion, and
cerebrovascular accidents, which are persistent structural impair-
ments, and persistent states of unconsciousness, for example,
coma and cerebrovascular diseases (Ross, 1988).
The pronunciation of “syncope” can differ from person to per-
son; however, [síηk epi] seems to be generally accepted, meaning
“strike” or “cut-off” in ancient Greek.
The human autonomic nervous system regulates the sys-
temic arterial pressure to maintain constant cerebral perfusion
under conditions of uneven fluid shift caused by postural change.
Syncope is the state of failure of this regulating function.
Many forms of syncope are preceded by a prodromal state
that often includes dizziness and loss of vision, loss of hearing,
loss of pain and feeling, nausea and abdominal discomfort, weak-
ness, cold sweating, a feeling of hotness, palpitations and other
phenomena, which are often called “presyncope” (Reeves and
Swenson, 2012).
In the present review, the process of syncope progression is
described with two types of sympathetic change.
AUTONOMIC CONTROL OF THE CARDIOVASCULAR SYSTEM
Baroreceptors are situated at the carotid sinus and the aortic
arch; they monitor the arterial pressure and transmit informa-
tion on this pressure to the central nervous system (Mathias and
Bannister, 2002). Upon extension of the arterial wall by the rais-
ing of the blood pressure, the baroreceptors (stretch receptors)
generate an impulse depending on the arterial pressure via the
glossopharyngeal nerve (CN IX) from the carotid sinus and via
the vagus nerve (CNX) from the aortic arch, and transmit the sig-
nals to the nucleus tractus solitarius (NTS) in the medulla (Iwase,
2002, 2006, 2009).
From the NTS, excitatory information is sent via the gluta-
matergic neurons to the caudal ventrolateral medulla (CVLM),
where inversion of positive and negative signs is executed. The
CVLM then transmits GABAergic (using γ-amino butyric acid as
a neurotransmitter) neurons to the rostral ventrolateral medulla
(RVLM). The topographical regional differentiation has been
established (Dampney, 2004).
The RVLMneurons are considered to be premotor neurons for
the preganglionic efferent neurons whose cell bodies are situated
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in the intermediolateral nucleus (IML), with synapses to the
preganglionic B-fiber neurons, and which exit from the spinal
cord as white rami (Netter, 1983).
On the other hand, input from NTS to the nucleus ambiguus
and the dorsal nucleus of the vagus modulates the activity of
the vagal nerve, innervating the heart and presphincters of the
resistant vessels, and causing decrease in heart rate and cardiac
contractility (Patten, 1996).
As for the sympathetic efferent pathway, the cardiac sym-
pathetic activity, and the activity of muscle sympathetic nerves
innervating skeletal muscles play a role in blood pressure reg-
ulation. Muscle sympathetic nerve activity (MSNA) can be
recorded microneurographically from human peripheral nerves
in situ, which is the only baromodulatory sympathetic nerve
activity directly recordable in humans (Figure 1). The tech-
niques to record MSNA are described elsewhere (Mano et al.,
2006).
These pathways provide a negative feedback mechanism to
suppress the sympathetic nerve activity while the vagus nerve
activity is activated when blood pressure rises, and facilitate the
sympathetic nerve activity and suppress the vagus nerve activity
when blood pressure drops.
THE AUTONOMIC NERVOUS SYSTEM AND SYNCOPE
How is the autonomic nervous system involved in the onset of
syncope? It is primarily responsible for sympathetic responses
toward environmental challenges. The most frequent challenge
triggering syncope might be a postural change (Figure 1).
Syncope or fainting associated with orthostatic challenge includes
vasovagal syncope (or in a wider sense, neurally mediated
syncope) and orthostatic syncope (or orthostatic intolerance).
The symptoms of these two situations seem to be the same, but
the pathophysiology is different; they involve opposite directions
of pathways of the autonomic nervous system.
In the following sections, syncope from the perspectives of the
autonomic nervous system is described, based on the premise that
no structural or conduction disorder is present in the heart.
VASOVAGAL SYNCOPE (OR IN A WIDER SENSE, NEURALLY
MEDIATED SYNCOPE)
The concept of vasovagal syncope was first proposed by Lewis
in 1932, with primary symptoms of hypotension and bradycar-
dia. Vasovagal syncope is triggered by an exaggerated sympathetic
response to a situation; in other words, sympathoexcitation pre-
cedes the onset.
The Bezold-Jarisch reflex plays an important role in the onset
of this type of syncope. This reflex is generated by the cerebral
hypoperfusion due to vagal-activation-mediated sympathosup-
pression for the protection of myocardium (Wallin and Sundlöf,
1982). This vagal activation may be caused by hyperactivity of
the left ventricular wall, which activates the stretch receptors in
the wall and trabeculae, and in turn the C-fiber afferents to NTS,
which triggers bradycardia and decreasedmyocardial contractility
(Salo et al., 2007).
Several factors are known to exacerbate and accelerate the
vasovagal syncope including (1) fatigue, dehydration, and hypo-
volemia due to hemorrhage, followed by reduced venous return,
(2) blood shift and pooling in the lower body, (3) hypersensitivity
of the stretch receptors in the left ventricular wall, and (4) fear,
emotional stress, and reaction to pain (Fenton et al., 2000).
Among these, (3) is the trigger that is considered to be essential
for the Bezold-Jarisch reflex.
FIGURE 1 | Responses of microneurographically recorded muscle sympathetic nerve activity during orthostatic challenge. MSNA is sparsely
discharged in a supine position, but is remarkedly enhanced as the tilt angle becomes large.
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An analysis of the polygraph of the vasovagal syncope indi-
cated that there are three phases in the onset of vasovagal syn-
cope. The changes during 60◦ head-up tilt and polygraph trace
(Figure 2) and flow charts are described below (Figure 3).
(1) Stage I: oscillation phase (Sugiyama et al., 1996; Iwase, 2002,
2009; Schwartz et al., 2013)
In this stage I, the sympathetic nerve activity (MSNA) and blood
pressure display an oscillation pattern with the levels been well
maintained. The time lag fromMSNA discharge to blood pressure
rise by the constriction of arterioles is approximately 4–5 s, while
the time lag from the blood pressure rise to the vasodilatation by
the suppression of sympathetic nerve activity is approximately
1 s from the descending pathway in the medulla oblongata to
ECG
Heart rate
Blood pressure
Respiration 
curve
Integrated 
MSNA
Transient HR increase
Gradual BP fall
BP maintenance
Disordered breathing
Ceased MSNA
Cardiac arrest and recovery
(min)
Vagal overdrive and 
Sudden bradycardia
FIGURE 2 | Polygraph of vasovagal syncope. Over the course of syncope progression in three stages, syncope onset develops at the stage III.
FIGURE 3 | Progression of vasovagal syncope from stage I to III.
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the peripheral vasodilating sphincter muscles via the synapse in
the sympathetic chain to the postganglionic C-fiber; the time
delay from the baroreceptor to the recording site of microneu-
rography. The sympathetic discharge induces a blood pressure
rise. This double feedback mechanism oscillates to maintain the
blood pressure. In stage I, blood pressure wave and heart rate
oscillate with a frequency of 0.1Hz (10 s period), and the low
frequency component (LF) of heart rate variability is enhanced.
This phase includes mutual increases in both sympathetic and
vagal activities.
(2) Stage II: imbalance phase (Iwase, 2002, 2009; Kamiya et al.,
2005; Schwartz et al., 2013)
At this stage, venous return is reduced due to the failure to com-
pensate for the enhanced venous pooling, which makes blood
pressure maintenance difficult. The tidal volume is raised to
increase the venous return. Failure of the double feedback mech-
anism arises with the enhanced power of the high frequency
component (HF) of the blood pressure wave and heart rate
variability. The falling blood pressure due to decreased stroke
volume cannot be compensated for by only the peripheral vaso-
constriction, inducing an extremely elevated heart rate. This
tachycardia compensates for the reduced stroke volume, which
could not be compensated for by decreased venous return or
circulatory blood volume. In this state, cardiac echography some-
times reveals parallel movement of the interventricular septum
and the left ventricular wall, which is called “paradoxical move-
ment.” It is estimated that this state involves the sympathetic nerve
activity being overwhelmed by the parasympathetic nerve activity,
and the reciprocal relationship between the diastolic blood pres-
sure andMSNA, denoting the baroreflex function, disappears late
in this phase.
(3) Stage III: catastrophe phase (Iwase, 2002, 2009; Iwase et al.,
2002)
In spite of the effort to maintain the blood pressure by an
increased heart rate, the stage transitions to stage III, when a
sudden heart rate drop with the cessation of MSNA is observed,
resulting in an immediate fall in blood pressure. Some patients
experience cardiac arrest simultaneously with cold sweat, nau-
sea, blackout, and loss of consciousness. Dominant activation
of parasympathetic nerve activity occurs concomitantly with
sympathosuppression. In “neurally mediated syncope,” this stage
corresponds to the classification of cardiosuppressive, vasosup-
presive, or mixed types, which are based on whether the sup-
pressive drive is dominant over cardiac or vasomotor sympathetic
drives or both.
Therefore, sympathoactivation is observed, followed by sud-
den tachycardia, which triggers the onset of vasovagal syncope or
neurally mediated syncope.
ORTHOSTATIC HYPOTENSION OR ORTHOSTATIC
INTOLERANCE
The orthostatic hypotension or orthostatic syncope, or ortho-
static intolerance associated with postural change is caused by
the response failure or lack of sympathetic nerve activity to an
orthostatic challenge. A change in posture from a supine to an
upright position in humans induces a fluid shift of 300–800mL
from the thoracic cavity to the lower body, including abdom-
inal cavity or legs, resulting in a reduction in venous return.
This causes a stroke volume decrease, which in turn activates the
sympathetic nervous system via the arterial baroreflex and car-
diopulmonary reflex. This sympathoactivation induces increases
in heart rate, cardiac contractility, and peripheral resistance, while
arterial blood pressure is maintained and cerebral blood flow is
maintained constant.
In the case of activation failure, hypotension develops just
after the postural change, sometimes progressing to fainting or
syncope. The essence of orthostatic hypotension is failure of the
compensation of the fluid shift that follows postural change.
The largest difference from the neurally mediated syncope or
vasovagal syncope is the latency of syncope onset after the ortho-
static challenge. Usually, neurally mediated syncope or vasovagal
syncope is induced when the individuals maintain an upright
position for a comparatively long duration, possibly >10min,
whereas orthostatic hypotension develops in a short period. In
tilt studies on 66 subjects, the onset latency was reported to
be >1min for 58 and >2min for the remaining 8 individuals
(Gehrking et al., 2005). One more large difference from neurally
mediated or vasovagal syncope is that there are no prodromal
symptoms before the onset, namely, vagal symptoms, includ-
ing cold sweating or nausea. Therefore, syncope without vagal
symptoms usually progresses with onset 2min after a change of
posture.
There are four causes of compensatory failure: (1) hypov-
olemia, (2) increased pooling in the lower body, (3) failure to acti-
vate the sympathetic activity, and (4) failure of vasoconstriction
upon sympathetic vasoconstrictive stimulation.
(1) Hypovolemia. Hypovolemia is the most prevalent cause of
orthostatic hypotension, having associations with a hot envi-
ronment, dehydration, hemorrhage, diarrhea, Addison’s dis-
ease, and administration of diuretics. Hypovolemia results in
a fluid shift to the lower body, causing insufficient venous
return, stroke volume, and cardiac output, which lowers
cerebral perfusion and induces syncope. A large fluid shift
increases the heart rate, but usually insufficiently. If the
increase is exaggerated, this might be a cause of neurally
mediated or vasovagal syncope. In this case, the blood pres-
sure might be maintained for several minutes, while gradual
blood pressure decrease might be a cause. Here, the differ-
ence between neurally mediated or vasovagal syncope and
orthostatic hypotension might be reduced responsiveness of
the sympathetic nerve activity to fluid shift.
(2) Increased pooling in the lower body. This occurs due to (3)
or (4) below, or due to the increased pooling in the lower
body in pathological conditions including vascular disease
that reduces the elasticity of the vessels, as seen in varices
or pregnancy. The mechanism of development is the same
as in (1).
(3) Failure to activate the sympathetic activity. Any disorder that
impairs the baroreflex function is included in this category,
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including carotid deafferentation, carotid sinus neuropathy,
primary autonomic failure (Shy-Drager type of multiple sys-
tem atrophy, MSA-P), pure autonomic failure, Parkinson’s
disease with autonomic failure, and acute pandysautono-
mia. In addition to the primary autonomic failures, sec-
ondary ones include diabetic neuropathy, amyloid neuropa-
thy, chronic renal failure, alcoholic neuropathy, spinal cord
injury, brain tumors, and postoperative symptoms of lum-
bar sympathectomy for the treatment of Buerger’s disease or
Raynaud’s syndrome all have an impaired efferent sympa-
thetic pathway, which induces marked pooling of the body
fluid (Hasegawa and Koike, 2004). One more state that
causes orthostatic hypotension is depression. Structural brain
abnormalities are associated with depression in the elderly,
suggesting a link between vascular diseases to white mat-
ter atrophy. Gordon et al. (2011) reported the association
between the degree of orthostatic hypotension and white
matter hyperintensity volume in the depression group indi-
cating that systolic blood pressure drops may be a factor
contributing to white matter lesions in depression in the
elderly.
(4) Attenuation of vasoconstrictor response to sympathetic stimu-
lation. Resistant vessels constract to enhance peripheral resis-
tance, resulting in a rise in arterial blood pressure, while lack
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Blood Pressure↑
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FIGURE 4 | Progression of orthostatic hypotension after 3 days of simulated microgravity exposure, dry immersion.MSNAwas gradually decreased, and
blood pressure dropwas also observed progressively. At 60 s after the tilt, gradually blood pressure fell, andMSNAwas suppressed, while heart ratewas elevated.
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or attenuation of the vasoconstrictor response to sympathetic
stimulation might be the cause of orthostatic hypotension.
This attenuated response is primarily caused by the admin-
istration of vasodilative agents including α-adrenoreceptor
blockers (e.g., prazosin), calcium antagonists (nifedipine),
prostaglandin E1 (limaprost), or nitroglycerin. We previously
reported that although the microneurographically recorded
sympathetic nerve activity is not altered, the effectiveness of
the sympathetic activity on blood flow reduction is atten-
uated (Iwase et al., 2000). Orthostatic intolerance that is
sometimes observed after long exposure to microgravity or
FIGURE 5 | Changes in MSNA discharges before and after
administration of L-threo-3, 4-dihydroxyphenylserine (L-DOPS). Before
the administration, there were few MSNA discharges, and enhancement
due to tilting of the bed at 40◦ was small (left plate). The discharges
became apparent 1 h after L-DOPS administration and were further
enhanced by 40◦ head-up tilting (right plate).
a long period of bed rest is partly caused by this attenuated
vasoconstrictive response to sympathoexcitation. In this case,
the heart rate is not usually reduced or is in fact elevated by
blood pressure reduction although MSNA gradually ceases
(Figure 4).
SYMPATHETIC NERVE ACTIVITY RECORDING DURING
SYNCOPE
Several examinations have been proposed to investigate the
pathophysiology of syncope, among which we propose recording
the MSNA from the tibial nerve microneurographically simulta-
neously with ECG, non-invasive continuous blood pressure wave
(Finapres, Finomonitor, Jentow, etc.), and fluid shift measure-
ments by the bioimpedancemethod. Several investigations related
to syncope with polygraphic recording have been reported by
the recording of microneurographically recorded MSNA, among
which Kamiya et al. reported the disappearance of 10 s oscil-
lation in MSNA and blood pressure in tilt-induced syncope
(2005), Ichinose et al. reported gradual blood pressure drop
with disappearance of 10 s oscillation in LBNP (lower body
negative pressure)-induced syncope (2006), and Cooke et al.
reported oscillation disappearance in LBNP induced syncope
(2009). Vagal suppression seemed to be classified into cardio-
suppressive and vasosuppressive types, including a mixed type
(Brignole et al., 2001, 2004). These two types were also evidenced
by the MSNA recording by Vaddadi et al. (2010) and Fu et al.
(2012), which showed suppression ofMSNA, sudden bradycardia,
or both. Thus, these reports clarified the pathophysiology of the
progress of syncope by recording microneurographic MSNA and
continuous blood pressure. In other words, in cardiosuppressive
type, sudden bradycardia occurs without MSNA disappearance,
FIGURE 6 | Responses of sympathetic nerve activity at the onset of syncope.
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whereas MSNA ceases in vasosuppressive type. These two types
of vasovagal syncope should be registered.
In contrast to the activation-suppression process of MSNA
in vasovagal syncope, the inability to follow the sympathetic
nerve activity to hypotension is considered to cause the ortho-
static intolerance. Clarification of the pathophysiology is dif-
ficult because MSNA is seldom recorded from patients with
such neurological impairments who are likely to have ortho-
static hypotension. We have recorded Shy-Drager syndrome
(multiple system atrophy, autonomic failure type), and reported
that although MSNA appeared not to be discharged from
the tibial nerve, administration of L-threo-DOPS (L-threo-3,4-
dihydroxyphenylserine), a precursor of noradrenaline, amelio-
rated the orthostatic intolerance and induced MSNA discharge
from the tibial nerve (Kachi et al., 1988, Figure 5). The same
phenomena were also observed in MSA-P with postprandial
hypotension, in that the appearance of MSNA improved the
symptom by the use of a nose drop of vasopressin (Hakusui et al.,
1991).
Thus, these changes recorded by polygraphy during the fluid
shift maneuver provided measures for diagnosing orthostatic
hypotension or vasovagal syncope (Figure 6). By the response of
the sympathetic nervous system, we can differentially describe
the underlying pathophysiology of orthostatic hypotension and
vasovagal (or neutrally mediated) syncope.
CONCLUSION
The sympathetic nervous system can control the cardiovascular
function, and its failure results in syncope; however, responses
of the system by microneurographically recorded MSNA would
determine the pathophysiology of the onset and progression of
syncope. An effective treatment could be achieved by the analysis
of this mechanism.
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